Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-12-20FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004% TRAVOPROST — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' Travoprost ophthalmic solution 0.004% as a generic product under an Original Application.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) [Phase 3]
Phase 3 trial reporting non-inferiority of PRO-122 ophthalmic solution compared to KRYTANTEK Ofteno in primary open-angle glaucoma and ocula…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 trial of netarsudil ophthalmic solution in Japanese and Japanese-American subjects with open-angle glaucoma or ocular hypertension c…
-
FDA approval · 2019-11-08FDA Approved: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION — Original Application (Micro Labs Limited)
FDA approved a generic dorzolamide hydrochloride ophthalmic solution from Micro Labs Limited as an original application to lower intraocular…
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 non-inferiority trial comparing PRO-067 ophthalmic solution to Ofteno in primary open-angle glaucoma and ocular hypertension was ter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma [Phase 2]
Phase 2 trial assessing safety and efficacy of ENV515 Travoprost Extended Release (XR) in patients with Bilateral Ocular Hypertension or Pri…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients [Phase 3]
Phase III clinical trial evaluating TJO-002 for primary open-angle glaucoma and ocular hypertension has completed.
-
FDA approval · 2019-09-03FDA Approved: LATANOPROST — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for LATANOPROST (latanoprost) from Aurobindo Pharma Limited, establishing a generic version of latanop…
-
FDA approval · 2019-08-19FDA Approved: TAFLUPROST — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's tafluprost ophthalmic solution as an Original Application (generic) product.
-
FDA approval · 2019-08-09FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals Inc.'s original application for Dorzolamide Hydrochloride as a generic drug. It is used to lower intrao…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma [Phase 1]
Phase 1 trial of SHP639 eye drops in adults with primary open-angle glaucoma or ocular hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide [Phase 2]
Phase 2 clinical trial of a fixed combination therapy (timolol-brimonidine-dorzolamide) for primary open-angle glaucoma and ocular hypertens…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy [Phase 4]
Phase 4 trial comparing brinzolamide/brimonidine combo to brimonidine alone for preventing intraocular pressure rise after Nd-YAG laser caps…
-
FDA approval · 2019-06-25FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a generic dorzolamide hydrochloride and timolol maleate ophthalmic solution for lowering intraocular pressure in open-angle gla…
-
FDA approval · 2019-06-19FDA Approved: BIMATOPROST — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for BIMATOPROST from Somerset Therapeutics, LLC.
-
FDA approval · 2019-06-13FDA Approved: DORZOLAMIDE AND TIMOLOL — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's dorzolamide hydrochloride and timolol maleate ophthalmic solution as an original application (ANDA 205295…
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) [Phase 2]
Phase 2 clinical trial of netarsudil ophthalmic solution in primary open angle glaucoma or ocular hypertension has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 double-masked study of PG324 ophthalmic solution in open-angle glaucoma and ocular hypertension has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of PG324 ophthalmic solution for elevated intraocular pressure has been completed with…
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure [Phase 2]
Phase 2 trial assessing daily oral CF101 for safety and efficacy in subjects with elevated intraocular pressure; study completed with result…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® [Phase 4]
Phase 4 trial update evaluating SIMBRINZA® as an adjunctive therapy to DUOTRAV® in open-angle glaucoma and ocular hypertension, terminated w…
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma [Phase 4]
A Phase 4 trial evaluating the impact of inhaled corticosteroids on intraocular pressure in patients with controlled glaucoma, with complete…
-
FDA approval · 2019-05-02FDA Approved: TIMOLOL MALEATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings' original ANDA for timolol maleate, a generic ophthalmic beta-blocker intended to reduce intraocular pre…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 double-masked trial evaluating PG324 Ophthalmic Solution in open-angle glaucoma and ocular hypertension has completed with results…
-
FDA approval · 2019-04-12FDA Approved: BIMATOPROST — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved the original application for bimatoprost from Alembic Pharmaceuticals Inc., authorizing a generic version of the glaucoma medic…